Newsroom

News Releases

Mallinckrodt to Present at Jefferies 2013 Global Healthcare Conference in London

DUBLIN--(BUSINESS WIRE)--Nov. 13, 2013-- Mallinckrodt plc (NYSE: MNK), a global specialty pharmaceutical and global medical imaging company, will present at the Jefferies 2013 Global Healthcare Conference in London on Wednesday, November 20, 2013. Mark Trudeau, President and Chief Executive Officer of Mallinckrodt, will represent the company in a session scheduled to begin at 9:20 am London Time. The meeting will be held at the Waldorf Hilton in London.

Individuals who are unable to attend the meeting in person will be able to view a live video and webcast at: http://mallinckrodt.com/investor_relations. A replay of the presentation will be available on the website for 14 days following the conclusion of the meeting. Mallinckrodt will also have the presentation materials posted on the company’s website.

ABOUT MALLINCKRODT:

Mallinckrodt is a global specialty pharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company’s Specialty Pharmaceuticals segment includes branded and generic drugs and active pharmaceutical ingredients, and the Global Medical Imaging segment includes contrast media and nuclear imaging agents. Mallinckrodt has approximately 5,500 employees worldwide and a commercial presence in roughly 70 countries. The company’s 2013 revenue totaled $2.2 billion. To learn more about Mallinckrodt, visit www.mallinckrodt.com.

Source: Mallinckrodt

Mallinckrodt
John Moten, 314-654-6650
Vice President, Investor Relations
john.moten@mallinckrodt.com
or
Lynn Phillips, 314-654-3263
Manager, Media Relations
lynn.phillips@mallinckrodt.com